I. Haloob

Effect of Low-Sodium versus Conventional Sodium Dialysate on Left Ventricular Mass in Home and Self-Care Satellite Facility Hemodialysis Patients: A Randomized Clinical Trial.

A. Vandal, K. Rabindranath, R. Gabriel, 2020, Journal of the American Society of Nephrology : JASN.

Update: Rationale and design of the Sodium Lowering In Dialysate (SoLID) trial: a randomised controlled trial of low versus standard dialysate sodium concentration during hemodialysis for regression of left ventricular mass

A. Vandal, K. Rabindranath, R. Gabriel, 2015, BMC Nephrology.

Assessment of Dietary Sodium Intake Using the Scored Salt Questionnaire in Autosomal Dominant Polycystic Kidney Disease

David W. Johnson, K. Sud, D. Harris, 2020, Nutrients.

Rationale and design of the Sodium Lowering In Dialysate (SoLID) trial: a randomised controlled trial of low versus standard dialysate sodium concentration during hemodialysis for regression of left ventricular mass

A. Vandal, K. Rabindranath, R. Gabriel, 2013, BMC Nephrology.

Associations of a facility level decrease in dialysate sodium concentration with blood pressure and interdialytic weight gain.

M. Marshall, H. Thein, I. Haloob, 2007, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Effect of antimicrobial locks for tunneled hemodialysis catheters on bloodstream infection and bacterial resistance: a quality improvement report.

M. Marshall, W. M. van der Merwe, E. Curry, 2009, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Rationale and design of the myocardial microinjury and cardiac remodeling extension study in the sodium lowering in dialysate trial (Mac-SoLID study)

A. Vandal, K. Rabindranath, R. Gabriel, 2014, BMC Nephrology.

Equity and diversity in the nephrology workforce in Australia and New Zealand

A. Webster, K. Wyburn, N. Boudville, 2022, Internal medicine journal.

Prescribed Water Intake in Autosomal Dominant Polycystic Kidney Disease

David W. Johnson, Marie E. Edwards, Adriana V. Gregory, 2021, NEJM Evidence.

Randomised controlled trial to determine the efficacy and safety of prescribed water intake to prevent kidney failure due to autosomal dominant polycystic kidney disease (PREVENT-ADPKD)

David W. Johnson, Marie E. Edwards, B. Erickson, 2018, BMJ Open.

PrescribedWater Intake in Autosomal Dominant Polycystic Kidney Disease

David W. Johnson, Marie E. Edwards, Adriana V. Gregory, 2021 .

Participant Perceptions in a Long-term Clinical Trial of Autosomal Dominant Polycystic Kidney Disease

K. Sud, M. Howell, G. Rangan, 2023, Kidney medicine.

Randomised controlled trial to determine the efficacy and safety of prescribed water intake to prevent kidney failure due to autosomal dominant polycystic kidney disease (PREVENT-ADPKD)

David W. Johnson, Marie E. Edwards, B. Erickson, 2018, BMJ Open.